These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16098242)

  • 21. Cyclooxygenase 2: from inflammation to carcinogenesis.
    Ristimäki A
    Novartis Found Symp; 2004; 256():215-21; discussion 221-6, 259-69. PubMed ID: 15027493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclooxygenase as a target in lung cancer.
    Brown JR; DuBois RN
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4266s-4269s. PubMed ID: 15217972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells.
    Di Popolo A; Memoli A; Apicella A; Tuccillo C; di Palma A; Ricchi P; Acquaviva AM; Zarrilli R
    Oncogene; 2000 Nov; 19(48):5517-24. PubMed ID: 11114729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COX-2 and prostanoid receptors: good targets for chemoprevention.
    Kawamori T; Wakabayashi K
    J Environ Pathol Toxicol Oncol; 2002; 21(2):149-53. PubMed ID: 12086401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.
    Tanigawa T; Watanabe T; Hamaguchi M; Sasaki E; Tominaga K; Fujiwara Y; Oshitani N; Matsumoto T; Higuchi K; Arakawa T
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G148-56. PubMed ID: 12958020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
    Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC
    Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor.
    Hasegawa K; Ohashi Y; Ishikawa K; Yasue A; Kato R; Achiwa Y; Nishio E; Udagawa Y
    Int J Oncol; 2005 May; 26(5):1419-28. PubMed ID: 15809736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid.
    Stolfi C; Fina D; Caruso R; Caprioli F; Sarra M; Fantini MC; Rizzo A; Pallone F; Monteleone G
    Biochem Pharmacol; 2008 Feb; 75(3):668-76. PubMed ID: 17981262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
    Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M
    Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point.
    Arber N
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1852-7. PubMed ID: 18708371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenase-2 inhibitors in lung cancer.
    Ramalingam S; Belani CP
    Clin Lung Cancer; 2004 Jan; 5(4):245-53. PubMed ID: 14967078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclooxygenase inhibitors not inhibit resting lung cancer A549 cell proliferation.
    Duan W; Zhang L
    Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):317-21. PubMed ID: 16618538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.
    Ye YN; Wu WK; Shin VY; Bruce IC; Wong BC; Cho CH
    Carcinogenesis; 2005 Apr; 26(4):827-34. PubMed ID: 15637091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of cyclooxygenase-2 by tetramethylpyrazine and its effects on A549 cell invasion and metastasis.
    Zheng CY; Xiao W; Zhu MX; Pan XJ; Yang ZH; Zhou SY
    Int J Oncol; 2012 Jun; 40(6):2029-37. PubMed ID: 22344367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance of prostate cancer cell lines to COX-2 inhibitor treatment.
    Wagner M; Loos J; Weksler N; Gantner M; Corless CL; Barry JM; Beer TM; Garzotto M
    Biochem Biophys Res Commun; 2005 Jul; 332(3):800-7. PubMed ID: 15907789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
    Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
    Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment.
    Lee JM; Yanagawa J; Peebles KA; Sharma S; Mao JT; Dubinett SM
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):208-17. PubMed ID: 18304833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of 11β-Hydroxysteroid Dehydrogenase Type II Suppresses Lung Carcinogenesis by Blocking Tumor COX-2 Expression as Well as the ERK and mTOR Signaling Pathways.
    Chang J; Xue M; Yang S; Yao B; Zhang B; Chen X; Pozzi A; Zhang MZ
    PLoS One; 2015; 10(5):e0127030. PubMed ID: 26011146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential and rationale for COX-2 inhibitors in lung cancer.
    Krysan K; Reckamp KL; Sharma S; Dubinett SM
    Anticancer Agents Med Chem; 2006 May; 6(3):209-20. PubMed ID: 16712449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.